TAK-880
/ Takeda
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 23, 2022
A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults
(clinicaltrials.gov)
- P=N/A | N=72 | Completed | Sponsor: Takeda | Recruiting ➔ Completed
Preclinical • Trial completion • Immunology
1 to 1
Of
1
Go to page
1